Navigation Links
Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
Date:10/12/2009

ple Myeloma

Multiple myeloma (MM) is the second most common hematologic cancer and results from an abnormality of plasma cells, usually in the bone marrow. In the United States, more than 50,000 people are living with MM and approximately 20,000 new cases are diagnosed annually(i). Worldwide, more than 180,000 people are living with MM and approximately 86,000 new cases are diagnosed annually(ii).

About Carfilzomib

Carfilzomib is the first in a new class of highly specific proteasome inhibitors. Carfilzomib produces specific and sustained inhibition of the proteasome, leading to apoptosis in cancer cells with minimal off-target effects. In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in hematologic and solid tumors, including multiple myeloma and renal cancer. Proteolix is currently conducting a comprehensive clinical development program evaluating carfilzomib for the treatment of multiple myeloma, including two ongoing Phase 2 clinical trials of single-agent carfilzomib, one in heavily pre-treated relapsed and refractory patients with progressive disease who have failed to respond to prior treatment, and a second in relapsed patients stratified by prior treatment with bortezomib. A Phase 1b clinical trial of carfilzomib in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma is also ongoing. In addition, based on promising Phase 1 results, Proteolix is conducting a single-agent Phase 1b/2 clinical trial of carfilzomib in patients with recurrent or advanced solid tumors. For the latest information regarding ongoing carfilzomib clinical trials, please visit www.clinicaltrials.gov.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is devel
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report
2. To: All Persons and Entities Who Purchased or Acquired Bristol-Myers Common Stock Between the Close of the Market on March 21, 2006, Through August 8, 2006, Inclusive
3. Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group.
4. Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America
5. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
6. Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018
7. MedServe to be Acquired by Stericycle for $185 Million
8. Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money
9. Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
10. All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. (Sunrise) Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The Class)
11. Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 The discounts that some ... products do not include various skin creams or oil ... skin tightening cream discounts inside of its cost saving ... is now available to offer a direct source for ... products available for sale. Although the guide includes pricing, ...
(Date:7/23/2014)... Men and women who are married ... insurance based on national averages. The Quotes Pros company ... to its comprehensive tool this year to help married ... , Providers that are now underwriting plans on a ... one or two clicks. The intelligent platform used to ...
(Date:7/23/2014)... July 23, 2014 The puffiness that ... using non-surgical techniques, according to a new guide published ... serum sold in the U.S. is now available for ... , The complimentary guide that is now published is ... with under eye puffiness. While surgical techniques are available, ...
(Date:7/23/2014)... 2014 Recently, iFitDress.com, a professional company of ... of 2014 vintage party dresses . Aside from that, ... current discount is up to 63% off. , “We are ... These new items are all manufactured by trustworthy and experienced ... until July 30; it is great to provide such a ...
(Date:7/23/2014)... 23, 2014 In preparation for National ... Millennium Treatment Group is providing tips on choosing a ... society ever since man first figured out the process ... has existed since shortly thereafter. Its basis lies in ... then developing a way to combat that problem while ...
Breaking Medicine News(10 mins):Health News:Skin Tightening Cream Discounts Revealed in New Cost Saving Guide at Consumer Portal 2Health News:Cheap Life Insurance Rates for Married Couples Added to Search System at Insurer Portal Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3
... embryos or adult mice to behave like stem cells ... in an immediate early publication of the journal Cell. ... stem cells" (iPS) behaved physically and genetically as stem ... used to treat a host of diseases, such as ...
... a ban on Coke and Pepsi by the Kerala Government, the ... forth a proposal to stop the sale// and production of 11 ... ,Top brass in the companies are very unhappy over these moves, ... company which is not in sync with the reports from ...
... has called for moratoriums on consumer advertising which promotes ... that the products// are safe and that they work. ... group has urged the U.S. Food and Drug Administration ... after a drug or device obtains regulatory approval before ...
... found in a study that instead of dieting, which could ... and thereby a desire// to change it, women who accept ... lowest body mass index (BMI). ,The researchers have ... disorders. Tracy Tylka, assistant professor of psychology and one of ...
... is a rare condition that affects children as well ... named anakinra could alleviate// symptoms and bring down the ... in the August 10 issue of the New England ... Research Program of the National Institute of Arthritis and ...
... a sharp rise in polio cases in the country with ... as against a total of 66 last year.// ... upper house, Friday that the transmission of poliovirus may continue ... target". ,In a written answer he said that ...
Cached Medicine News:Health News:Only A Few Differentiating Factors Between Adult And Stem Cells 2Health News:Drug Advertising needs to be Limited 2Health News:Study Finds Healthier Women Are Those Who Accept The Way They Look 2Health News:NOMID Symptoms Helped By Arthritis Drug 2Health News:NOMID Symptoms Helped By Arthritis Drug 3
(Date:7/23/2014)... 23, 2014  Dompe, a leader in R&D for new ... rhNGF (Recombinant Human Nerve Growth Factor) has been designated as ... (FDA). The candidate drug, developed by the ... for the treatment of neurotrophic keratitis, a degenerative corneal disease ... and is currently without a cure. This is the second ...
(Date:7/23/2014)... 2014 Research and Markets ... Medical Kits and Trays - Global Strategic Business ... http://photos.prnewswire.com/prnh/20130307/600769 This ... Kits and Trays in US$ Thousands by the ... Trays, Custom Basin Kits, Custom Ob/Gyn Kits, General ...
(Date:7/23/2014)... 2014  ArmaGen, a privately held biotechnology company ... neurological disorders, announced today that it has entered ... Shire plc to develop AGT-182, an investigational enzyme ... the central nervous system (CNS) and somatic (body-related) ... II, Hunter syndrome is a rare, severe, progressive ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3
... Model 3085 temporary pacemaker is designed to ... for temporary atrial or ventricular or A-V ... where such pacing modes are indicated for ... Model 3085 can be used to measure ...
... a unique left ventricular assist device that helps ... being used in a small group of patients ... of an FDA-approved Feasibility Study. The patient can ... power source for minutes or hours. The Kantrowitz ...
... system provides an ideal solution for ... laboratory, satellite lab and the clinic ... method with wedge-smear technology, the ADVIA ... in a safe enclosed environment. The ...
... T600 treadmill has streamlined design, ... a brushless DC motor and ... unique system that operates on ... in smooth operation, remarkably low ...
Medicine Products: